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Abstract
 
Salmonella typhimurium
 
 causes an invasive disease in mice that has similarities to human typhoid.
 
A type III protein secretion system encoded by 
 
Salmonella
 
 pathogenicity island 2 (SPI2) is essen-
tial for virulence in mice, as well as survival and multiplication within macrophages. Reactive
nitrogen intermediates (RNI) synthesized by inducible nitric oxide synthase (iNOS) are in-
volved in the control of intracellular pathogens, including 
 
S. typhimurium
 
. We studied the effect
of 
 
Salmonella
 
 infection on iNOS activity in macrophages. Immunofluorescence microscopy
demonstrated efficient colocalization of iNOS with bacteria deficient in SPI2 but not wild-type
 
Salmonella
 
, and suggests that the SPI2 system interferes with the localization of iNOS and 
 
Sal-
monella
 
. Furthermore, localization of nitrotyrosine residues in the proximity was observed for
SPI2 mutant strains but not wild-type 
 
Salmonella
 
, indicating that peroxynitrite, a potent antimi-
crobial compound, is excluded from 
 
Salmonella
 
-containing vacuoles by action of SPI2. Altered
colocalization of iNOS with intracellular 
 
Salmonella
 
 required the function of the SPI2-encoded
type III secretion system, but not of an individual “
 
Salmonella
 
 translocated effector.” Inhibition
of iNOS increased intracellular proliferation of SPI2 mutant bacteria and, to a lesser extent, of
wild-type 
 
Salmonella
 
. The defect in systemic infection of a SPI2 mutant strain was partially re-
stored in iNOS
 
 
 
/
 
 
 
 mice. In addition to various strategies to detoxify RNI or repair damage
due to RNI, avoidance of colocalization with RNI is important in adaptation of a pathogen to
an intracellular life style.
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Introduction
 
Phagocytes employ an array of enzymatic activities to inacti-
vate and degrade phagocytosed organisms. Among other an-
timicrobial effector mechanisms, phagocytes possess enzyme
systems that are involved in the production of reactive oxy-
gen intermediates (ROI)
 
*
 
 and reactive nitrogen intermedi-
ates (RNI) with activities against a wide array of pathogens.
Infection experiments with knockout mice defective in
 
gp91
 
phox
 
 (ROI production), inducible nitric oxide synthase
(iNOS; or NOS2, RNI production), and both enzymes in-
dicated that these enzymes contribute to the control of bac-
terial infections (1). The combined activity of gp91
 
phox
 
 and
iNOS is required for the generation of peroxynitrite, one of
the most potent antimicrobial effectors of macrophages (2).
Although RNI- and ROI-generating pathways are usually
highly efficient and result in the killing of phagocytosed bac-
 
teria, several intracellular pathogens, such as 
 
Salmonella enter-
ica
 
, have evolved strategies to circumvent the action of these
bactericidal activities of their host cells.
Infections with 
 
S. enterica
 
 constitute a significant public
health problem in most countries. 
 
S. enterica
 
 causes self-lim-
ited, acute intestinal inflammations, manifesting clinically
with diarrhea and vomiting. However, infections with cer-
tain serovars of 
 
S. enterica
 
 can lead to systemic diseases with
significant lethality such as typhoid fever. Two hallmarks of
pathogenesis of 
 
Salmonella
 
 infections are the invasion of non-
phagocytic cells and the survival and replication within host
cells, for example macrophages. Many events during patho-
genesis of systemic 
 
Salmonella
 
 infections have been studied in
detail in the model system of murine salmonellosis, a ty-
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phoid fever-like infection caused by 
 
S. enterica
 
 serotype Ty-
phimurium (
 
Salmonella typhimurium
 
) in susceptible mice.
Type III secretion systems (TTSS) are a family of highly
evolved protein secretion systems in Gram-negative patho-
gens. TTSS translocate, in a contact-dependent manner,
effector proteins into the eukaryotic host cell (3). The
function of a TTSS encoded by 
 
Salmonella
 
 pathogenicity is-
land 1 (SPI1) is important for interactions of 
 
S. typhimurium
 
with the epithelial mucosa, such as invasion of enterocytes
(4) and the induction of diarrhea (5). During systemic
infections macrophages represent an important site for
replication of 
 
S. typhimurium
 
 (6, 7). Mutant strains of 
 
S.
typhimurium
 
 unable to survive and replicate within
macrophages are also severely attenuated in virulence in the
animal model of infection (8). Survival and replication of 
 
S.
typhimurium
 
 in macrophages requires the function of a large
number of proteins. These functions range from biosynthe-
sis of macromolecules that are limited in the phagosomal
environment, enzyme systems involved in the repair of
damages due to antimicrobial activities of the host cells, to
virulence factors that actively modulate host cell functions
(9, 10). 
 
Salmonella
 
 pathogenicity island 2 (SPI2) harbors
genes encoding a second TTSS for virulence proteins in 
 
S.
enterica
 
 (for a review, see reference 11). The function of
SPI2 genes is absolutely required for the progression of sys-
temic infections by 
 
S. typhimurium
 
 in the model of murine
salmonellosis (12) and the proliferation within infected or-
gans such as liver and spleen (13). Furthermore, the role of
SPI2 in intracellular replication and survival has been dem-
onstrated (14, 15, 16). On the cellular level, the function of
SPI2 proteins affects vesicle trafficking in host cells (17).
SPI2 is also required to prevent the localization of
NADPH-oxidase to 
 
Salmonella
 
-containing vesicles (SCVs)
of the infected host cell, an activity leading to the evasion
of intracellular 
 
Salmonella
 
 from oxidative damage (18, 19).
Infections with 
 
Salmonella
 
 induce iNOS expression (for a
review, see reference 20) and recent studies demonstrated
that the function of iNOS is required to control the prolif-
eration of 
 
S. typhimurium
 
 in infected organs (21) and within
infected macrophages (22). As the function of SPI2 is also
required for both phenotypes, we asked if SPI2 is involved
in the control of iNOS expression or activity, or may con-
trol the production of RNI and their effects on intracellular
 
S. typhimurium.
 
 To investigate the cellular microbiology of
this antimicrobial effector mechanism in more detail, we
established an in vitro system to study the effects of 
 
S. ty-
phimurium
 
 on expression of iNOS and production of RNI.
In this study we report that intracellular 
 
S. typhimurium
 
 em-
ploy the TTSS of SPI2 to prevent the localization of iNOS
with SCVs. To our knowledge, this is the first observation
that a pathogen can alter the cellular localization of iNOS
to protect itself from the damaging effects of RNI and the
combined effects of RNI and ROI.
 
Materials and Methods
 
Bacterial Strains.
 
Bacterial strains used in this study are listed
in Table I. 
 
Salmonella enterica
 
 serovar Typhimurium (
 
S. typhimu-
rium
 
) NCTC 12023 was used as wild-type strain and all mutant
strains were constructed in the 
 
S. typhimurium
 
 12023 background.
For colocalization experiments 
 
S. typhimurium
 
 strains were trans-
formed with plasmid pFPV25.1 constitutively expressing green
fluorescent protein (GFP; reference 23).
 
Construction of Mutations in Salmonella-translocated Effector Genes.
 
The method of one-step inactivation of chromosomal genes (24)
was applied. Briefly, primers with 56 to 65 bases length including
20 bases priming sequences for the template pKD4 and 36 to 45
bases homologous to the respective flanking regions of the gene
of interest have been constructed. PCR reactions were performed
with the Expand High Fidelity PCR system (Roche) using pKD4
as template. PCR products were purified, digested with DpnI,
and gel purified. The PCR products were transformed into 
 
S
 
. 
 
ty-
phimurium
 
 cells harboring pKD46 and grown in the presence of
arabinose to induce the Red recombinase. Recombinant clones
were selected by plating on Luria-Bertani (LB)-agar containing
50 
 
 
 
g/ml kanamycin. Kanamycin-resistant colonies were further
checked for chromosomal insertion of the antibiotic resistance
cassette by PCR using primers k1 and k2 (24). The proper inser-
tions of the antibiotic resistance cassettes within the various 
 
Sal-
monella
 
-translocated effector (STE) genes were confirmed by
DNA sequencing. Finally, the mutant alleles were moved into a
fresh strain background by P22 transduction according to stan-
dard procedures (25).
 
Cell Culture.
 
The murine macrophage cell line RAW267.4
was obtained from American Type Culture Collection, and
maintained in DMEM containing 10% heat-inactivated FCS (In-
vitrogen/Life Technologies) at 37
 
 
 
C under 5% CO
 
2
 
. The cells
were washed gently with PBS and removed from the flasks by
scraping. The cells were suspended in 24-well plates for experi-
ments at the density of 5 
 
 
 
 10
 
4
 
 cells per well. Peritoneal macro-
phages were harvested from thioglycollate-elicited peritoneal lav-
ages from C57BL/6 mice and plated in DMEM supplemented
 
Table I.
 
Bacterial Strains Used in This Study
 
Strain designation
Relevant
characteristics Remarks/reference
 
S. typhimurium
 
Wild-type Identical to ATCC 14028
NCTC 12023
P8G12
 
ssrB
 
::mTn
 
5
 
13
P2D6
 
ssaV
 
::mTn
 
5
 
13
P11D10
 
sscA
 
::mTn
 
5
 
13
P7G2
 
ssaC
 
::mTn
 
5
 
13
HH101
 
sseA
 
::
 
aphT
 
15
HH102
 
sseB
 
::
 
aphT
 
15
HH104
 
sseC
 
::
 
aphT
 
15
P3H6
 
sifA
 
::mTn
 
5
 
44
P7B12
 
sipC
 
::mTn
 
5
 
45
MvP374
 
 
 
sifB
 
::
 
aph
 
This study
MvP375
 
 
 
sspH1
 
::
 
aph
 
This study
MvP376
 
 
 
sspH2
 
::
 
aph
 
This study
MvP377
 
 
 
sseJ
 
::
 
aph
 
This study
MvP378
 
 
 
sseI
 
::
 
aph
 
This study
MvP379
 
 
 
slrP
 
::
 
aph
 
This study 
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with 10% FCS. After 2 h at 37
 
 
 
C, the cells were washed twice
with PBS and the adherent cells were incubated overnight in
DMEM plus 10% FCS. Cells were always cultured in antibiotic-
free media.
 
Survival of S. typhimurium After In Vitro Exposure to Nitrosative
Stress.
 
Overnight cultures of wild-type 
 
S. typhimurium
 
 and the
 
ssaV
 
 mutant strain were diluted to OD
 
600
 
 of 0.2. S-nitrosoglu-
tathione (GSNO; Calbiochem) and sodium nitrite (NaNO
 
2
 
;
Sigma-Aldrich) were prepared freshly in distilled water, adjusted
to pH 5.0, and added to 1 ml LB broth at various concentrations.
SIN-1 (Calbiochem) was dissolved in distilled water and added to
1 ml LB at various concentrations. Subsequently, 100 
 
 
 
l of the
diluted culture was added to each tube. The tubes were incubated
at 37
 
 
 
C under shaking conditions. After 3 and 9 h of exposure se-
rial dilutions were made and plated onto Mueller-Hinton agar for
the enumeration of surviving bacteria.
 
Infection of Macrophages. Bacteria were grown overnight in LB
broth in glass test tubes with aeration in a “roller drum” (New
Brunswick Scientific). The OD at 600 nm of the cultures was ad-
justed to 0.2 and 1 ml of the bacterial suspension was centrifuged,
washed twice with PBS, and resuspended in DMEM. 10  l of
the bacterial suspension was further added to 1 ml of DMEM.
100  l of the bacterial suspension was added to the wells at a
multiplicity of infection (MOI) of 10 and the plates were centri-
fuged at 1,200 rpm for 5 min to synchronize the infection. The
plates were incubated at 37 C, 5% CO2 for 25 min. Subse-
quently, the plates were washed three times with PBS and incu-
bated with media containing 100  g/ml gentamicin for 1 h, fol-
lowed by media containing 10  g/ml of gentamicin for the rest
of the experiment. For infection of peritoneal macrophages, bac-
teria were opsonized for 30 min at 37 C with 10% normal mouse
serum before infection. Heat-killed bacteria were obtained by in-
cubation at 80 C for 10 min. This procedure did not affect the
integrity of the LPS.
Assessment of Intracellular Growth of Bacteria. Intracellular repli-
cation was assessed by means of the standard gentamicin assay
(26). After completion of the infection period, the cells were in-
cubated with 100  g/ml gentamicin for 1 h to kill the extracellu-
lar bacteria and subsequently with 10  g/ml gentamicin for the
rest of the time period. 2 and 16 h after infection, the supernatant
was removed and cells were washed three times with DMEM
(without serum) and lysed with 0.1% Triton X-100. Serial dilu-
tions of the lysates were plated onto LB agar to enumerate intra-
cellular bacteria.
For investigation of intracellular replication by microscopy, the
cells were grown on glass coverslips and infected with S. typhimu-
rium strains constitutively expressing GFP. The gentamicin pro-
tection was performed as described above, and cells were fixed
with 3% para-formaldehyde (PFA).
The inhibitors L-NMMA (l-monomethylarginine; Sigma-
Aldrich) or DPI (diphenyleneiodonium chloride) were added after
1 h of gentamicin treatment to avoid the possible effect of the in-
hibitors on the uptake of bacteria.
Infection Studies. C57BL/6 and iNOS /  mice were bred and
maintained under specific pathogen-free conditions in accordance
with national guidelines for animal studies. Groups of 6–7 mice
were infected by intraperitoneal injection of an inoculum consist-
ing of a mixture of 500 cfu wild-type S. typhimurium (NalR, KmS)
and 500 cfu of SPI2 mutant strain HH104 (NalS, KmR). At vari-
ous time points after infection, mice were killed by cervical dislo-
cation and livers and spleens were removed aseptically. Organs
were homogenized in 1 ml of PBS and the organ burdens of
wild-type S. typhimurium and the SPI2 mutant strain were deter-
mined by plating serial dilutions on LB-agar containing 50  g/ml
nalidixic acid or 50  g/ml kanamycin.
Determination of NO Production. NO was measured as its end
product nitrite using the Griess reagent as described previously
(27). Culture supernatants (50  l) were mixed with 100  l of
Griess reagent (1% sulfanilamide, 0.1% N-(1-napthyl)-ethylenedi-
amine dihydrochloride and 2.5% orthophosphoric acid). After 10
min, absorbance at 570 nm was measured in a microplate ELISA
reader (Bio-Rad Laboratories). The concentration of nitrite in
the culture supernatant was determined with reference to the
standard curve using sodium nitrite. All data represent the mean
value of triplicates   SD.
Immunoblotting. RAW267.4 cells were seeded in 6-well plates
(4   105 cells/well) and infected. Cells were lysed in SDS-PAGE
sample buffer and boiled for 5 min at 100 C. Aliquots containing
equal amounts of protein (20  g) were loaded onto a 6% gradient
polyacrylamide gel, run under reducing conditions, and trans-
ferred onto nitrocellulose membranes. The membranes were
treated with 5% bovine serum albumin for 1 h to block nonspe-
cific binding, rinsed, and incubated with rabbit polyclonal anti-
bodies against mouse iNOS (raised against peptide amino acids
(aa) 1125–1144, BioTrend) for 1 h. The blots were further
treated with goat anti rabbit IgG-horseradish peroxidase conju-
gate (AP-Biotech; dilution 1:3,000) for 1 h. The immune com-
plex on the blots was detected with enhanced chemiluminescence
substrate (AP-Biotech) and exposed to Eastman Kodak Co. XAR
x-ray film.
Immunofluorescent Staining of iNOS and Peroxynitrite. RAW
267.4 cells were seeded onto glass coverslips and infected as de-
scribed before. The antibodies were diluted in PBS containing
5% goat serum, 2% BSA, and 0.1% saponin. For immuno-staining
of iNOS, cells were incubated with 1:500 dilutions of rabbit anti-
sera raised against aa 1125–1144 (BioTrend) or aa 1137–1144 of
mouse iNOS (donated by Dr. C. Bogdan, University of Erlan-
gen, Erlangen, Germany). For detection of peroxynitrite forma-
tion, cells were incubated with a 1:500 dilution of a rabbit antise-
rum raised against nitrotyrosine (Upstate Biotechnology) for 1 h.
After washing with PBS, the cells were incubated with Cy3-con-
jugated goat anti–rabbit IgG antibody (Dianova) for 30 min. Af-
ter washing, the cells were inspected for localization of iNOS or
peroxynitrite using a fluorescence microscope or a confocal laser-
scanning microscope (Leica) using filter sets for FITC (510 nm
excitation, 530 nm emission) and TRITC (566 nm excitation,
590 nm emission). Images were further processed using the Leica
TCS software package.
Results
Induction of Nitrite Production by RAW267.4 Macrophages
Requires Live Salmonella but Does Not Require Bacterial Inter-
nalization. The role of RNI during experimental salmo-
nellosis in murine hosts has recently been demonstrated
(21, 22). To elucidate the role of RNI in the cellular mi-
crobiology of Salmonella, we first investigated how a cul-
tured macrophage-like cell line reacts to infection with S.
typhimurium. RAW267.4 macrophages were infected with
S. typhimurium wild-type and the NO response as measured
by nitrite accumulation was studied. An increase in the
MOI resulted in a gradual increase of the nitrite production
by the RAW267.4 cells at early time after infection (Fig. 1
A). 8 h after infection, no significant difference in nitrite1158 Salmonella Protection Against Reactive Nitrogen Intermediates
production was observed after infection at various MOI in
the range of 10 to 150. In contrast, macrophages infected
with heat-killed bacteria did not exhibit significant nitrite
accumulation after 8 h (Fig. 1 B). After 24 h, accumulation
of nitrite was detectable but lower than that observed with
live Salmonella. This residual nitrite accumulation may be
due to LPS, which is a prime inducer of NO response (28).
No nitrite accumulation was detected in macrophage cul-
tures separated from the Salmonella inoculum by a mem-
brane, indicating that contact was required for induction of
NO synthesis (Fig. 1 C). However, phagocytosis per se was
not required for the NO production, as inhibition of
phagocytosis by cytochalasin D did not inhibit the induction
of nitrite production by Salmonella (Fig. 1 C). Infection
with bacteria grown with aeration to stationary phase or
bacteria cultured under O2 limitation resulted in similar
levels of NO production (Fig. 1 D). Also, opsonization of
the inoculum did not affect the induction of NO produc-
tion (Fig. 1 D). Phagocytosis of latex beads alone did not
result in nitrite production by RAW267.4 cells (data not
shown), implying that live Salmonella set a specific signal for
NO induction early after infection.
Wild-type S. typhimurium and Mutant Strains in SPI2 In-
duce Similar NO Responses in Macrophages. The requirement
of bacterial viability led us to investigate whether gene
products required for intracellular proliferation of S. typhi-
murium are affecting the NO production. Here, we focused
on the role of SPI2 genes. Our experiments revealed no
significant difference between the NO response induced by
infection with wild-type S. typhimurium and various mu-
tants in the SPI2 locus (Fig. 2 A). The SPI2 mutants in-
duced as high levels of NO accumulation as wild-type Sal-
monella. Furthermore, no difference in the cellular amounts
of iNOS protein was observed in macrophages infected
with wild-type S. typhimurium or various SPI2 mutants
(Fig. 2 C). These observations indicate that SPI2 function
is not directly affecting the NO production or the cellular
levels of iNOS.
The induction of iNOS expression by effector proteins
of SPI1, such as SipC, has been reported recently (29). We
observed similar levels of NO synthesis after infection with
wild-type Salmonella and different strains deficient in SPI1,
such as a sipC strain (Fig. 2 B). SPI1-mediated invasion of
macrophages by Salmonella has cytotoxic effects on macro-
phages (for a review, see reference 30). Under the assay
conditions applied in our study, bacteria were grown to
Figure 1. Induction of iNOS by RAW267.4 macrophages requires live
Salmonella. (A) RAW267.4 cells were infected with wild-type Salmonella at
various MOI and nitrite in the supernatant was measured by the Griess re-
action 4 and 8 h after infection. (B) RAW267.4 macrophages were in-
fected with heat-killed Salmonella and the nitrite was measured 8 and 24 h
after infection. The data represent the mean   SD of three independent
experiments done in triplicate. (C) RAW267.4 macrophages were in-
fected with wild-type Salmonella at a MOI of 10 under various experimen-
tal conditions as indicated, and nitrite production was measured 8 h after
infection. After adding the bacteria to the macrophages and centrifugation,
infection took place for 0, 10, 25, or 60 min. In further assays, macrophages
were infected for 25 min, but were separated from the bacteria by a 0.4
 M filter, or cytochalasin D was added to the macrophages at 1  g/ml be-
fore infection. not inf., not infected. (D) Effect of bacterial culture condi-
tions on nitrite production. Wild-type S. typhimurium was grown for 16 h
in LB media without aeration as standing cultures or with aeration in test
tubes in a roller drum. If indicated, the bacteria were opsonized by incuba-
tion with 10% normal mouse serum for 30 min. Infection was performed
at a MOI of 10 and nitrite production was assayed after 16 h.
Figure 2. Nitrite production
by RAW267.4 macrophages in-
fected with wild-type Salmonella
and SPI2 mutant strains. (A)
RAW267.4 macrophages were
infected at a MOI of 10 with
different SPI2 mutants and the nitrite was measured in the supernatant af-
ter 8 h. (B) Infection was performed as before with wild-type S. typhimu-
rium and an isogenic strain deficient in sipC encoded by SPI1. wt, wild-
type. (C) Western blot analysis of iNOS expression in noninfected
RAW267.4 macrophages, and macrophages infected with wild-type S.
typhimurium or strains harboring mutations in SPI2 genes ssaV or ssrA.1159 Chakravortty et al.
stationary phase, thus reduced in expression of SPI1, non-
invasive and noncytotoxic. Therefore, in our experimental
system mutations in the secretion system of SPI1 or effector
proteins of SPI1 are unlikely to affect iNOS expression.
Inhibition of iNOS Enhances Intracellular Proliferation of S.
typhimurium and Rescues Mutants Deficient in SPI2. As
iNOS has been recently shown to be one of the potent can-
didate molecules in controlling the Salmonella infection (22),
we further looked at the intracellular growth of wild-type
S. typhimurium and SPI2 mutant strains. Irrespective of the
high nitrite production, wild-type Salmonella proliferated
rapidly inside host cells, while SPI2 mutant strains had re-
duced rates of intracellular proliferation. Determination of
intracellular bacteria in RAW267.4 macrophages at 2 and
16 h after infection indicated a 60-fold increase for S. ty-
phimurium wild-type compared with a 5 to 7-fold increase
for mutants in SPI2 genes. L-NMMA, a competitive inhib-
itor of NO synthases, dose dependently inhibited the nitrite
production by macrophages infected with wild type S. ty-
phimurium (Table II). Inhibition of iNOS by L-NMMA in-
creased the intracellular proliferation of the SPI2 mutants
(Fig. 3). This observation indicates that iNOS contributes to
the intracellular killing of Salmonella. However, the presence
of L-NMMA also resulted in increased intracellular prolifer-
ation of the wild-type strain, which suggests that a propor-
tion of wild-type Salmonella was also killed by RNI (Fig. 3).
To control if the observed effects are the result of higher
susceptibility of SPI2 mutant strains to nitrosative damages,
in vitro tests were performed (Fig. 4). Wild-type S. ty-
phimurium and a representative SPI2 mutant strain (ssaV) were
killed to the same extend by GSNO, NaNO2, or SIN-1.
Therefore, increased intracellular survival of SPI2 mutant
strains in the presence of L-NMMA is not the result of
higher sensitivity of these strains to nitrosative damage.
Localization of iNOS in Salmonella-infected Macrophages Is
Dependent on SPI2 Function. As the previous experiments
clearly demonstrated a role of RNI in controlling the intra-
Table II. Induction of Nitrite Production by 
RAW267.4 Macrophages
Nitrite
L-NMMA Noninfected Infected
 M  M  M
0 0 8.9   0.9
5 0 2.4   0.3
10 0 0.4   0.6
100 0 0.0   0.0
RAW267.4 macrophages were infected with wild-type S. typhimurium
at an MOI of 10. Noninternalized bacteria were removed by washing
followed by killing with gentamicin. After infection L-NMMA was
added as indicated and 8 h after infection, nitrite levels in the culture
supernatant were assayed by the Griess reaction.
Figure 3. Intracellular proliferation of Salmonella in the presence or ab-
sence of iNOS inhibitor L-NMMA. RAW267.4 macrophages were in-
fected with wild-type (wt) S. typhimurium and various mutant strains in
SPI2 genes at a MOI of 10. Non-internalized bacteria were removed by
washing and killed by gentamicin. L-NMMA was added at a concentra-
tion of 10  M if indicated. The number of intracellular bacteria was de-
termined by plating serial dilutions of macrophage lysates on LB-agar for
counting of cfu. Intracellular replication was expressed as the ratio of cfu
at 2 to 16 h after infection.
Figure 4. In vitro survival of S. typhimurium under different nitrosative stress conditions. Wild-type (circles) or SPI2 deficient (ssaV mutant, triangles)
S. typhimurium were exposed to various concentrations of GSNO (A) or NaNO2 (B) in LB medium (adjusted to pH 5.0) or SIN-1 (C) in LB medium
(adjusted to pH 7.0). At 3 h (open symbols) or 9 h (filled symbols) after exposure serial dilutions were plated and cfu were counted. Results are expressed
as mean cfu   SD of two independent experiments in triplicate.1160 Salmonella Protection Against Reactive Nitrogen Intermediates
cellular proliferation of Salmonella, we set out to localize
iNOS in Salmonella-infected macrophages. RAW267.4
macrophages or peritoneal macrophages were infected with
wild-type S. typhimurium and various SPI2 mutants and an-
alyzed by confocal laser-scanning microscopy for the local-
ization of iNOS. In case of macrophages infected with
wild-type S. typhimurium, iNOS was only rarely colocal-
ized with the bacteria and a diffuse staining for iNOS was
observed (Fig. 5). In contrast, in macrophages infected with
a SPI2 mutant strain defective in ssaV, iNOS frequently
colocalized with the bacteria (Fig. 5). The iNOS staining
was dense around the SPI2-deficient bacteria. Comparable
results were obtained with an antiserum raised against aa
1,125–1,144 (Fig. 5) and an antiserum raised against aa
1137–1144 of mouse iNOS (data not shown). Similar pat-
terns of colocalization with iNOS were obtained with vari-
ous strains harboring mutations in SPI2 genes sseB, ssaV,
ssaJ, ssrA, or ssrB. Previous work demonstrated that the vir-
ulence defect of a strain harboring a mutation in sseB can
be complemented by a plasmid-born copy of sseB (15).
Analysis of a sseB strain harboring psseB revealed the same
pattern of iNOS localization as observed for wild type Sal-
monella (data not shown).
We next investigated whether the altered cellular local-
ization of iNOS is a result of reduced intracellular prolifer-
ation of mutant strains in SPI2 or directly related to SPI2
function and analyzed infections with an isogenic strain
proficient for SPI2 function but defective in purD. The
purD mutant is deficient in purine metabolism and attenu-
ated in virulence (31) and intracellular proliferation (data
Figure 5. Localization of iNOS in Sal-
monella-infected macrophages. RAW267.4
macrophages and mouse peritoneal macro-
phages (PM) were infected with GFP-
expressing wild-type (wt) S. typhimurium or
SPI2 mutant strain defective in ssaV. Non-
internalized bacteria were killed by addition
of gentamicin. At 12 h after infection, the
cells were fixed and permeabilized for immu-
nostaining. iNOS was detected by incuba-
tion with a polyclonal antibody against
iNOS and a Cy3-labeled secondary anti-
body. The localization of iNOS (red) and S.
typhimurium (green) was analyzed by fluo-
rescence microscopy (not shown) and con-
focal laser-scanning microscopy. Colocaliza-
tion of S. typhimurium and iNOS resulted in
orange to red staining of the bacterial cells.1161 Chakravortty et al.
not shown) to a similar extent as the SPI2-deficient strains.
Although the number of intracellular purD bacteria was
lower than those of wild-type Salmonella,  purD bacteria
were not colocalized with iNOS (data not shown).
The proportion of bacterial cells colocalized with iNOS
after different time intervals was quantified (Fig. 6 A). At 8
or 16 h after infection, the proportion of wild-type S. ty-
phimurium colocalized with iNOS remained lower than
those of SPI2 mutant strains. Similar to a recent report by
Webb et al. (32) we did not observe significant colocaliza-
tion to either strain at earlier time points after infection.
Our observations indicate that the altered localization of
iNOS is an effect of the function of SPI2. SPI2 mutant
strains are still able to survive and replicate, to a certain ex-
tent, in infected macrophages (15). This result is in line
with the observation that a significant percentage of SPI2
mutants ( 40%) was not associated with iNOS. Such bac-
teria may escape the macrophage defense and be able to
replicate intracellularly. On the other hand, a low percent-
age ( 10%) of wild-type Salmonella colocalized with iNOS,
indicating that RNI also control the intracellular prolifera-
tion of fully virulent bacteria.
Effect of Mutations in Genes for STEs on iNOS Delivery to
Salmonella-containing Phagosomes. A family for proteins
that are translocated by the TTSS of SPI2 is encoded by
genes outside of the SPI2 locus (33). The gene products,
namely SlrP, SspH1, SspH2, SifA, SifB, SseI, and SseJ are
referred to as STEs and have been proposed to interact
with host cell functions after translocation into the infected
host cell. We set out to analyze if an individual STE pro-
tein is required for the prevention of iNOS delivery to
SCVs and constructed a set of strains harboring mutations
in STE genes. These strains were analyzed for iNOS deliv-
ery to SCVs after infection of macrophages. In contrast to
strains deficient in the TTSS of SPI2, mutants in STE genes
had characteristics similar to wild-type Salmonella, i.e., only
5–10% of the intracellular Salmonella colocalized with
iNOS (Fig. 6 B). Colocalization of iNOS to the sifA strain
was observed more frequently ( 15%). A role of SifA for
maintenance of SCVs was observed (24) and this effector
may also, to a certain extend, interfere with iNOS delivery
to SCVs.
These observations indicate that a single STE is not suffi-
cient to modify the delivery of iNOS to SCVs. The con-
certed action of several STE or the function of further, yet
unknown effector proteins of the SPI2-encoded TTSS may
be required for this phenotype.
Peroxynitrite Formation in Salmonella-infected Macrophages Is
Localized with SPI2-deficient Bacteria. NO per se is not a
potent cytotoxic molecule and most potent bactericidal
effect of NO appears to be via a reaction with O2
  (2).
NO reacts with O2
  to yield peroxynitrite (OONO ).
Peroxynitrite generated in the cells cannot be detected di-
rectly, but sites of damage due to the reaction of perox-
ynitrite can be assessed by immunohistochemical staining
of nitrotyrosine. In case of macrophages infected with
wild-type Salmonella, the nitrotyrosine staining was not, or
to a low extent colocalized with the bacteria (Fig. 7). Sim-
ilar observations on the nitrotyrosine formation in S. ty-
phimurium–infected macrophages were recently reported
(22). In the case of SPI2 mutant strains, nitrotyrosine
staining was localized in the vicinity of the bacteria (Fig.
7), indicating events where proteins were targeted by for-
mation of peroxynitrite.
Control of Intracellular Proliferation of S. typhimurium in Pri-
mary Peritoneal Macrophages. After infection of primary
peritoneal macrophages with S. typhimurium, the nitrite
production was higher in primary macrophages (15   1.5
 M nitrite) than in the RAW267.4 cell line (8   0.5  M
nitrite). There was no difference observed in the nitrite
production between macrophages infected with wild-type
Salmonella or SPI2 mutant strains. Overall, the number of
intracellular wild-type Salmonella was lower than those in
RAW267.4 macrophages, but again only few events of
colocalization with iNOS or nitrotyrosine were observed.
On the other hand, in cells infected with SPI2 mutants,
colocalization with iNOS or nitrotyrosine was frequently
observed, suggesting that in primary macrophages iNOS
contributes to the killing of the SPI2 mutants and not of
wild-type Salmonella. Inhibition of iNOS by L-NMMA in-
Figure 6. Colocalization of iNOS with
wild-type  S. typhimurium and various
strains deficient in SPI2 genes or
“Salmonella translocated effectors.” (A)
RAW267.4 macrophages were infected
with wild-type S. typhimurium (wt) and
strains deficient in the SPI2-encoded se-
cretion system (ssaV, ssrA, ssaJ). At 2, 8,
or 16 h after infection, the percentage of
bacteria colocalized with iNOS was
scored by examining randomly selected 50
microscopic fields (1,000  magnifica-
tion) and counted for total green and
colocalized yellow or red bacteria. (B)
RAW267.4 macrophages were infected
with wild-type S. typhimurium, or mutant
strains in SPI2 (ssaV) or various STE genes
(sspH1, sspH2, sseI, sseJ, sifA, sifB, slrP). 8 h after infection, macrophages were processed for immuno-staining and colocalization was quantified as
described in panel A. The data represent two independent experiments.1162 Salmonella Protection Against Reactive Nitrogen Intermediates
creased the growth of intracellular wild-type Salmonella and
SPI2 mutant strains. Furthermore, in infection studies with
primary macrophages we used the inhibitor DPI, which in-
hibits both NADPH oxidase and iNOS. The addition of
DPI resulted in a higher recovery of intracellular bacteria
than L-NMMA (Fig. 8). The addition of phenylarsine ox-
ide, which inhibits only NADPH oxidase but not iNOS,
resulted in a lower recovery of intracellular bacteria com-
pared with DPI (data not shown). This observation indi-
cates additive effects of ROI and RNI in controlling intra-
cellular proliferation of S. typhimurium in macrophages.
Interaction of SPI2 and iNOS during Infection. The role
of iNOS in the control of Salmonella infection was analyzed
by comparison of systemic salmonellosis in iNOS /  and
iNOS /  mice. Here, we used a mixed infection model in
which a mixture of equal amount of wild-type S. typhimu-
rium and a SPI2 mutant strain was applied via the intraperi-
toneal route. At various time points after infection, the bac-
terial burden of each strain was determined in infected
organs, and the competitive index (CI) for wild-type S. ty-
phimurium versus SPI2 mutants was determined (Table III).
The CI is a highly sensitive and reproducible estimate of
the virulence of a mutant strain in competition with the
wild-type strain (24). In accordance with this previous
study, a SPI2 mutant strain was deficient in the coloniza-
tion of the C57BL/6 (iNOS / ) mice. At early time points
after infection, proliferation of wild-type and SPI2-defi-
Figure 7. Localization of peroxynitrite in
S. typhimurium-infected macrophages. In-
fection of RAW267.4 macrophages and
mouse peritoneal macrophages (PM) was
performed for 12 h as described in the leg-
end to Fig. 5. The sites of peroxynitrite for-
mation were detected by immunostaining
with an anti-nitrotyrosine antibody and a
Cy3-conjugated secondary antibody. Sam-
ples were analyzed by confocal laser-scanning
microscopy and representative images for
the localization of S. typhimurium expressing
GFP (green) and peroxynitrite (red) are
shown. Various levels of nitrotyrosine for-
mation were observed for the SPI2 mutant
strain. wt, wild-type.
Figure 8. Intracellular replication in primary macrophages. Peritoneal
macrophages were prepared from C57BL/6 mice and infected with S. ty-
phimurium wild-type (wt) or various strains harboring mutations in SPI2
genes. After infection, inhibitors L-NMMA (10  M) and DPI (10  M)
were added as indicated. The intracellular proliferation was determined as
described in the legend of Fig. 3.1163 Chakravortty et al.
cient  Salmonella was similar in iNOS /  and iNOS / 
mice. However, a dramatic difference was observed at the
late phase of infection. At day 5 after infection a CI of  
0.00005 was obtained for iNOS /  mice, indicating that
the SPI2-deficient strain was out-competed by wild-type
S. typhimurium. In contrast, in iNOS /  mice CI of 1.2 and
0.16 in liver and spleen, respectively, were determined
at day 5 after infection. These results demonstrate that
iNOS / , but not iNOS /  mice, are able to control the
proliferation of SPI2-deficient S. typhimurium, indicating an
interaction in vivo of SPI2 and RNI-dependent defense
mechanisms of the host.
Discussion
RNI produced by iNOS have important functions in
the host defense against intracellular pathogens such as
Leishmania spp., Mycobacterium spp., and Salmonella spp. (2,
34). Inhibition of iNOS resulted in increased bacterial bur-
dens in organs and reduced survival of Salmonella-infected
mice (35). An increase in the intracellular proliferation of
Salmonella was observed in macrophages after inhibition of
iNOS (22). Furthermore, it was recently demonstrated
that iNOS plays an important role in controlling the
growth of Salmonella at the later stages of infection in the
model of murine salmonellosis: iNOS /  mice succumbed
to infection with a S. typhimurium strain of intermediate
virulence several days after infection, while iNOS /  mice
survived the infection (21). Inhibition of iNOS also led to
increased intracellular replication of Salmonella in macro-
phages and mutant strains that downregulate the nitrite
production also showed increased proliferation in macro-
phages (36). These evidences suggest a role of iNOS in
Salmonella pathogenesis.
Salmonella possesses several systems to detoxify RNI as
well as enzymes to repair damages induced by the action of
RNI (for a review, see reference 2). Recent observations
also indicate that intracellular Salmonella utilize a variety of
mechanisms to actively avoid antimicrobial activities of
their host cells (17, 18). As RNI are important antimicro-
bial effector molecules of phagocytes, we analyzed here if
S. typhimurium also has mechanisms to prevent synthesis or
circumvent the effects of RNI. We are interested to under-
stand the cellular microbiology of SPI2, a virulence factor
that is essential for the proliferation of S. typhimurium
within infected host tissues and intracellular replication. No
difference was observed between wild-type Salmonella and
SPI2 mutants in terms of iNOS protein levels or nitrite
production, showing that SPI2 is not involved in reduction
of RNI production.
The subcellular localization of iNOS was dramatically
different in macrophages infected with wild-type Salmo-
nella or SPI2 mutants. We observed that iNOS was closely
localized with SPI2 mutant strains, but rarely with wild-
type bacteria. As SPI2 mutants show highly reduced intra-
cellular proliferation, the colocalization of iNOS with
SPI2 mutants suggests the involvement of nitrogen-
derived radicals in the killing of SPI2 mutants. Inhibition
of iNOS by the inhibitor L-NMMA resulted in increased
proliferation of SPI2-deficient Salmonella in macrophages,
indicating a role of RNI in limiting intracellular prolifera-
tion within macrophages.
The reaction of RNI with ROI generates peroxynitrite
(ONOO ), a reactive molecule with potent antimicrobial
activity against S. typhimurium in vitro (2). It was recently
reported that peroxynitrite did not colocalize with the
wild-type Salmonella and may not be responsible for the
killing of intracellular bacteria (22). In fact, we confirm that
peroxynitrite rarely colocalizes with wild-type Salmonella.
In contrast, nitrotyrosine residues were frequently located
in the vicinity of SPI2 mutants, indicating that the perox-
ynitrite formed can reach the target bacteria and may act as
a potent molecule to kill the bacteria. This observation
stresses the role of peroxynitrite in eradication of intracellu-
lar Salmonella. Production of ROI appears to be a crucial
defense mechanism in the early phase of Salmonella infec-
tions as mice deficient in the phagocyte oxidase succumb
shortly after infection (for a review, see reference 37). Dur-
ing the late phase of infection, the combined activities of
ROI and RNI appear to be important for the control of
proliferation of Salmonella in infected organs. We assume
that peroxynitrite formation is a potent antimicrobial
mechanism of macrophages and efficiently inactivates mi-
croorganisms that are not adapted to an intracellular life-
style by virulence factors such as SPI2.
The observations reported here raise important new
questions about the mode of delivery of iNOS to SCVs of
the host cell and how intracellular Salmonella influence the
Table III. Competitive Indexes (CI) of a SPI2-deficient Mutant versus Wild-type S. typhimurium After Infection of iNOS /  and 
iNOS /  Mice
Time after
infection (d)
CI in iNOS /  CI in iNOS / 
Liver Spleen Liver Spleen
2 0.24   0.056 0.075   0.035 0.52   0.69 0.066   0.091
3 0.0047   0.0026 0.00078   0.0001 0.0092   0.0016 0.0028   0.0005
5  0.000005  0.000005 1.20   0.49 0.16   0.041164 Salmonella Protection Against Reactive Nitrogen Intermediates
localization of iNOS. If Salmonella can actively prevent the
colocalization of iNOS with SCVs, under normal condi-
tions iNOS may be transported to phagosomes in a vecto-
rial fashion. iNOS of mouse macrophages is reported to re-
side not only free in the cytosol, but is also present in small
vesicles (38). This has led to suggestions that the targeted
delivery of such vesicles to the appropriate phagosomes
possibly allows the interaction between iNOS and the
pathogens, thereby exerting the antimicrobial activity. The
association of iNOS with actin has been reported (32), but
a recruitment of iNOS to phagosomes containing S. ty-
phimurium was not observed under the specific experimen-
tal conditions of the study.
We speculate that transport of iNOS and NADPH-oxi-
dase to phagosomes is tightly controlled to ensure that
highly reactive antimicrobial radicals are preferentially pro-
duced at the appropriate subcellular location, without caus-
ing damage to host cell structures. The first model for the
function of SPI2 postulates an inhibition of cellular traffick-
ing, i.e., by inhibition of transport of iNOS-containing
vesicles to SCVs. A second explanation of the phenotype
described here may be the altered structure of SCVs. Re-
cent observations indicate that intracellular S. typhimurium
employ the SPI2 system to interfere with the organization
of actin of the host cell and to accumulate actin at SCVs
(39). This difference between the phagosomal composition
of SCVs containing wild type Salmonella or SPI2 mutants
may affect the access of iNOS to the bacteria. The modifi-
cation of the pathogen-containing vesicle, or coating, in-
duced by the pathogen was also observed in macrophages
infected with M. tuberculosis (40).
A large number of STE proteins of the TTSS of SPI2
have been identified (33), and it is likely that the various ef-
fectors have different targets and functions in the host cell.
However, our study did not indicate a significant role of
single STE in protection of intraphagosomal Salmonella
against nitrosative damages. STE proteins may have over-
lapping or partially redundant functions in protection of in-
tracellular Salmonella, or additional, not yet characterized
effector proteins of the SPI2 are required for this function.
Various intracellular phenotypes in macrophages have
been related to the function of SPI2 of Salmonella: (a)
Uchiya et al. reported the inhibition of vesicular traffick-
ing as a function of SPI2 (17). (b) Vazquez-Torres et al.
observed that intracellular Salmonella employ the SPI2 sys-
tem to exclude the NADPH-oxidase from SCVs (18, 19).
(c) Finally, we report here that the SPI2 system is in-
volved in altering the localization of iNOS. Further work
has to reveal whether the different cellular phenotypes are
all consequences of the same function of SPI2, e.g., by a
general inhibition of cellular vesicle transport. It is likely
that the combined activities of NADPH-oxidase and
iNOS at the SCVs are required to generate potent antimi-
crobial effectors.
Finally, the Salmonella-induced production of RNI
might have deleterious effects on the host cells. If high
amounts of RNI are produced but proper delivery to
phagosomes is inhibited by SPI2, damage to the host cell
may occur. Such autotoxicity by incorrectly delivered anti-
microbial effector molecules might also contribute to in-
creased intracellular proliferation of Salmonella. It was
reported that uric acid, which quenches peroxynitrite for-
mation, improves killing of Salmonella by macrophages
(22), suggesting that the peroxynitrite formed cannot reach
the target bacteria and becomes cytotoxic to the host cell
itself. This effect may enable the spread of Salmonella from
infected macrophages and dissemination into other tissues,
finally leading to a systemic infection.
Other mechanisms have been described that also con-
tribute to the protection of bacteria against RNI and per-
oxynitrite. These include superoxide dismutase (41), fla-
vohemoglobin (42), and peroxynitrite reductase (43), that
are present in pathogenic bacteria and nonpathogenic rela-
tives. Several of these mechanisms contribute directly to
the virulence of S. enterica, while other mechanisms such as
superoxide dismutase are duplicated with redundant func-
tions (for a review, see reference 2). In contrast, the SPI2
locus represents an acquisition only present in the S. enterica
(13) and is considered as an adaptation to survival and repli-
cation in a host organism (10). The large number of bacte-
rial defense mechanisms evolved to counteract antimicro-
bial activities of RNI and peroxynitrite underline the role
of these mechanisms in the innate immunity of the host.
Our observations are summarized in the following
model for the interaction of Salmonella with macrophages:
macrophages react to the contact with bacteria with ex-
pression of iNOS and increased production of RNI. Salmo-
nella that invade macrophages or are taken up by phagocy-
tosis are confronted with the potent antimicrobial activity
of RNI produced by iNOS. In contrast to nonpathogenic
bacteria, Salmonella employs the TTSS encoded by SPI2 to
translocate effector proteins that prevent the colocalization
of iNOS and the SCVs, so that RNI cannot react with the
phagocytosed bacteria. In addition to bacterial mechanisms
that interfere with production of RNI, detoxification of
RNI, and repair of damage caused by RNI, the exclusion
of RNI- and ROI-producing enzymes appears to be an
important virulence mechanism of intracellular pathogens.
To our knowledge, S. typhimurium is the first example of a
pathogen that actively avoids the delivery of antimicrobial
effectors to the pathogen-containing vesicle by means of a
TTSS. It will now be of interest to analyze if other intra-
cellular pathogens use similar strategies to evade antimicro-
bial activities of their host cells.
We would like to thank Dr. M. Röllinghoff for generous support
of our work and Dr. C. Bogdan for providing antisera against
iNOS, iNOS /  mice, and for stimulating discussions. We are in-
debted to Cedric Cheminay for the preparation of primary macro-
phages and members of the Hensel lab for critical reading of the
manuscript.
This work was supported by the Deutsche Forschungsgemein-
schaft by grants HE 1964/2-3 and HE1964/4-2.
Submitted: 10 September 2001
Revised: 26 February 2002
Accepted: 4 March 20021165 Chakravortty et al.
References
1. Shiloh, M.U., J.D. MacMicking, S. Nicholson, J.E. Brause,
S. Potter, M. Marino, F. Fang, M. Dinauer, and C. Nathan.
1999. Phenotype of mice and macrophages deficient in both
phagocyte oxidase and inducible nitric oxide synthase. Immu-
nity. 10:29–38.
2. Nathan, C., and M.U. Shiloh. 2000. Reactive oxygen and
nitrogen intermediates in the relationship between mamma-
lian hosts and microbial pathogens. Proc. Natl. Acad. Sci.
USA. 97:8841–8848.
3. Hueck, C.J. 1998. Type III protein secretion systems in bac-
terial pathogens of animals and plants. Microbiol. Mol. Biol.
Rev. 62:379–433.
4. Galan, J.E. 2001. Salmonella interactions with host cells: type
III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53–86.
5. Wallis, T.S., and E.E. Galyov. 2000. Molecular basis of Sal-
monella-induced enteritidis. Mol. Microbiol. 36:997–1005.
6. Richter Dahlfors, A., A.M.J. Buchan, and B.B. Finlay. 1997.
Murine salmonellosis studied by confocal microscopy: Salmo-
nella typhimurium resides intracellularly inside macrophages
and exerts a cytotoxic effect on phagocytes in vivo. J. Exp.
Med. 186:569–580.
7. Finlay, B.B., and S. Falkow. 1989. Salmonella as an intracellu-
lar parasite. Mol. Microbiol. 3:1833–1841.
8. Fields, P.I., R.V. Swanson, C.G. Haidaris, and F. Heffron.
1986. Mutants of Salmonella typhimurium that cannot survive
within the macrophage are avirulent. Proc. Natl. Acad. Sci.
USA. 83:5189–5193.
9. Foster, J.W., and M.P. Spector. 1995. How Salmonella sur-
vive against the odds. Annu. Rev. Microbiol. 49:145–174.
10. Groisman, E.A., and H. Ochman. 1997. How Salmonella be-
came a pathogen. Trends Microbiol. 5:343–349.
11. Hensel, M. 2000. Salmonella Pathogenicity Island 2. Mol. Mi-
crobiol. 36:1015–1023.
12. Shea, J.E., M. Hensel, C. Gleeson, and D.W. Holden. 1996.
Identification of a virulence locus encoding a second type III
secretion system in Salmonella typhimurium. Proc. Natl. Acad.
Sci. USA. 93:2593–2597.
13. Shea, J.E., C.R. Beuzon, C. Gleeson, R. Mundy, and D.W.
Holden. 1999. Influence of the Salmonella typhimurium patho-
genicity island 2 type III secretion system on bacterial growth
in the mouse. Infect. Immun. 67:213–219.
14. Ochman, H., F.C. Soncini, F. Solomon, and E.A. Groisman.
1996. Identification of a pathogenicity island required for Sal-
monella survival in host cells. Proc. Natl. Acad. Sci. USA. 93:
7800–7804.
15. Hensel, M., J.E. Shea, S.R. Waterman, R. Mundy, T. Ni-
kolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, F. Fang,
and D.W. Holden. 1998. Genes encoding putative effector
proteins of the type III secretion system of Salmonella patho-
genicity island 2 are required for bacterial virulence and pro-
liferation in macrophages. Mol. Microbiol. 30:163–174.
16. Cirillo, D.M., R.H. Valdivia, D.M. Monack, and S. Falkow.
1998. Macrophage-dependent induction of the Salmonella
pathogenicity island 2 type III secretion system and its role in
intracellular survival. Mol. Microbiol. 30:175–188.
17. Uchiya, K., M.A. Barbieri, K. Funato, A.H. Shah, P.D. Stahl,
and E.A. Groisman. 1999. A Salmonella virulence protein that
inhibits cellular trafficking. EMBO J. 18:3924–3933.
18. Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D.W. Holden,
S.M. Lucia, M.C. Dinauer, P. Mastroeni, and F.C. Fang.
2000. Salmonella pathogenicity island 2-dependent evasion of
the phagocyte NADPH oxidase. Science. 287:1655–1658.
19. Gallois, A., J.R. Klein, L.A. Allen, B.D. Jones, and W.M.
Nauseef. 2001. Salmonella pathogenicity island 2-encoded
type III secretion system mediates exclusion of NADPH oxi-
dase assembly from the phagosomal membrane. J. Immunol.
166:5741–5748.
20. Cherayil, B.J., and D. Antos. 2001. Inducible nitric oxide
synthase and Salmonella infection. Microbes Infect. 3:771–776.
21. Mastroeni, P., A. Vazquez-Torres, F.C. Fang, Y. Xu, S.
Khan, C.E. Hormaeche, and G. Dougan. 2000. Antimicro-
bial actions of the NADPH phagocyte oxidase and inducible
nitric oxide synthase in experimental salmonellosis. II. Effects
on microbial proliferation and host survival in vivo. J. Exp.
Med. 192:237–248.
22. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischi-
ropoulos, and F.C. Fang. 2000. Antimicrobial actions of the
NADPH phagocyte oxidase and inducible nitric oxide syn-
thase in experimental salmonellosis. I. Effects on microbial
killing by activated peritoneal macrophages in vitro. J. Exp.
Med. 192:227–236.
23. Valdivia, R.H., and S. Falkow. 1997. Fluorescence-based iso-
lation of bacterial genes expressed within host cells. Science.
277:2007–2011.
24. Datsenko, K.A., and B.L. Wanner. 2000. One-step inactiva-
tion of chromosomal genes in Escherichia coli K-12 using PCR
products. Proc. Natl. Acad. Sci. USA. 97:6640–6645.
25. Maloy, S.R., V.L. Stewart, and R.K. Taylor. 1996. Genetic
Analysis of Pathogenic Bacteria. Cold Spring Harbor Labora-
tory Press, Cold Spring Harbor, New York.
26. Bowe, F., and F. Heffron. 1994. Isolation of Salmonella mu-
tants defective for intracellular survival. Methods Enzymol.
236:509–526.
27. Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S.
Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate,
nitrite, and nitrate in biological fluids. Anal. Biochem. 126:
131–138.
28. Raetz, C.R., R.J. Ulevitch, S.D. Wright, C.H. Sibley, A.
Ding, and C.F. Nathan. 1991. Gram-negative endotoxin: an
extraordinary lipid with profound effects on eukaryotic signal
transduction. FASEB J. 5:2652–2660.
29. Cherayil, B.J., B.A. McCormick, and J. Bosley. 2000. Salmo-
nella enterica serovar typhimurium-dependent regulation of in-
ducible nitric oxide synthase expression in macrophages by
invasins SipB, SipC, and SipD and effector SopE2. Infect. Im-
mun. 68:5567–5574.
30. Monack, D.M., W.W. Navarre, and S. Falkow. 2001. Salmo-
nella-induced macrophage death: the role of caspase-1 in
death and inflammation. Microbes Infect. 3:1201–1212.
31. Hensel, M., J.E. Shea, C. Gleeson, M.D. Jones, E. Dalton,
and D.W. Holden. 1995. Simultaneous identification of bac-
terial virulence genes by negative selection. Science. 269:400–
403.
32. Webb, J.L., M.W. Harvey, D.W. Holden, and T.J. Evans.
2001. Macrophage nitric oxide synthase associates with corti-
cal actin but is not recruited to phagosomes. Infect. Immun.
69:6391–6400.
33. Miao, E.A., and S.I. Miller. 2000. A conserved amino acid
sequence directing intracellular type III secretion by Salmo-
nella typhimurium. Proc. Natl. Acad. Sci. USA. 97:7539–7544.
34. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. Re-
active oxygen and reactive nitrogen intermediates in innate
and specific immunity. Curr. Opin. Immunol. 12:64–76.
35. Umezawa, K., T. Akaike, S. Fujii, M. Suga, K. Setoguchi, A.1166 Salmonella Protection Against Reactive Nitrogen Intermediates
Ozawa, and H. Maeda. 1997. Induction of nitric oxide syn-
thesis and xanthine oxidase and their roles in the antimicro-
bial mechanism against Salmonella typhimurium infection in
mice. Infect. Immun. 65:2932–2940.
36. Eriksson, S., J. Bjorkman, S. Borg, A. Syk, S. Pettersson, D.I.
Andersson, and M. Rhen. 2000. Salmonella typhimurium mu-
tants that downregulate phagocyte nitric oxide production.
Cell. Microbiol. 2:239–250.
37. Vazquez-Torres, A., and F.C. Fang. 2001. Oxygen-depen-
dent anti-Salmonella activity of macrophages. Trends Microbiol.
9:29–33.
38. Vodovotz, Y., D. Russell, Q.W. Xie, C. Bogdan, and C.
Nathan. 1995. Vesicle membrane association of nitric oxide
synthase in primary mouse macrophages. J. Immunol. 154:
2914–2925.
39. Meresse, S., K.E. Unsworth, A. Habermann, G. Griffiths, F.
Fang, M.J. Martinez-Lorenzo, S.R. Waterman, J.-P. Gorvel,
and D.W. Holden. 2001. Remodelling of the actin cytoskel-
eton is essential for replication of intravacuolar Salmonella.
Cell. Microbiol. 3:567–577.
40. Ferrari, G., H. Langen, M. Naito, and J. Pieters. 1999. A coat
protein on phagosomes involved in the intracellular survival
of mycobacteria. Cell. 97:435–447.
41. De Groote, M.A., U.A. Ochsner, M.U. Shiloh, C. Nathan,
J.M. McCord, M.C. Dinauer, S.J. Libby, A. Vazquez-Torres,
Y. Xu, and F.C. Fang. 1997. Periplasmic superoxide dis-
mutase protects Salmonella from products of phagocyte
NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad.
Sci. USA. 94:13997–14001.
42. Crawford, M.J., and D.E. Goldberg. 1998. Role for the Sal-
monella flavohemoglobin in protection from nitric oxide. J.
Biol. Chem. 273:12543–12547.
43. Bryk, R., P. Griffin, and C. Nathan. 2000. Peroxynitrite re-
ductase activity of bacterial peroxiredoxins. Nature. 407:211–
215.
44. Beuzon, C.R., S. Meresse, K.E. Unsworth, J. Ruiz-Albert, S.
Garvis, S.R. Waterman, T.A. Ryder, E. Boucrot, and D.W.
Holden. 2000. Salmonella maintains the integrity of its intra-
cellular vacuole through the action of sifA.  EMBO J. 19:
3235–3249.
45. Deiwick, J., T. Nikolaus, J.E. Shea, C. Gleeson, D.W.
Holden, and M. Hensel. 1998. Mutations in Salmonella
Pathogenicity Island 2 (SPI2) genes affecting transcription of
SPI1 genes and resistance to antimicrobial agents. J. Bacteriol.
180:4775–4780.